161 related articles for article (PubMed ID: 31655505)
1. Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI.
Saraç Ö; Alğin O; Beyazal M; Anlar FB; Varan A; Kansu AT
Turk J Med Sci; 2019 Dec; 49(6):1626-1633. PubMed ID: 31655505
[TBL] [Abstract][Full Text] [Related]
2. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening.
Levin MH; Armstrong GT; Broad JH; Zimmerman R; Bilaniuk LT; Feygin T; Li Y; Liu GT; Fisher MJ
Br J Ophthalmol; 2016 Apr; 100(4):510-4. PubMed ID: 26294105
[TBL] [Abstract][Full Text] [Related]
3. Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1.
Avery RA; Mansoor A; Idrees R; Trimboli-Heidler C; Ishikawa H; Packer RJ; Linguraru MG
Neurology; 2016 Dec; 87(23):2403-2407. PubMed ID: 27815398
[TBL] [Abstract][Full Text] [Related]
4. Optic nerve tortuosity in children with neurofibromatosis type 1.
Ji J; Shimony J; Gao F; McKinstry RC; Gutmann DH
Pediatr Radiol; 2013 Oct; 43(10):1336-43. PubMed ID: 23636538
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis Type 1: Description of a Novel Diagnostic Scoring System in Pediatric Optic Nerve Glioma.
Eid H; Crevier-Sorbo G; Aldraihem A; Menegotto F; Wilson N
AJR Am J Roentgenol; 2019 Apr; 212(4):892-898. PubMed ID: 30741560
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance diffusion tensor imaging (MRDTI) of the optic nerve and optic radiations at 3T in children with neurofibromatosis type I (NF-1).
Filippi CG; Bos A; Nickerson JP; Salmela MB; Koski CJ; Cauley KA
Pediatr Radiol; 2012 Feb; 42(2):168-74. PubMed ID: 21858653
[TBL] [Abstract][Full Text] [Related]
7. Quantitative MRI criteria for optic pathway enlargement in neurofibromatosis type 1.
Avery RA; Mansoor A; Idrees R; Biggs E; Alsharid MA; Packer RJ; Linguraru MG
Neurology; 2016 Jun; 86(24):2264-70. PubMed ID: 27170570
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of optic nerve diameters in individuals with neurofibromatosis and comparison of normative values in different pediatric age groups.
Tosun M; Güngör M; Uslu H; Anık Y
Clin Imaging; 2022 May; 85():83-88. PubMed ID: 35259715
[TBL] [Abstract][Full Text] [Related]
9. Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1.
Campagna M; Opocher E; Viscardi E; Calderone M; Severino SM; Cermakova I; Perilongo G
Pediatr Blood Cancer; 2010 Dec; 55(6):1083-8. PubMed ID: 20979170
[TBL] [Abstract][Full Text] [Related]
10. Delineation of the visual pathway in paediatric optic pathway glioma patients using probabilistic tractography, and correlations with visual acuity.
Hales PW; Smith V; Dhanoa-Hayre D; O'Hare P; Mankad K; d'Arco F; Cooper J; Kaur R; Phipps K; Bowman R; Hargrave D; Clark C
Neuroimage Clin; 2018; 17():541-548. PubMed ID: 29527480
[TBL] [Abstract][Full Text] [Related]
11. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort.
Falzon K; Drimtzias E; Picton S; Simmons I
Br J Ophthalmol; 2018 Oct; 102(10):1367-1371. PubMed ID: 29343527
[TBL] [Abstract][Full Text] [Related]
12. Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1.
Trevisson E; Cassina M; Opocher E; Vicenzi V; Lucchetta M; Parrozzani R; Miglionico G; Mardari R; Viscardi E; Midena E; Clementi M
J Neurooncol; 2017 Sep; 134(2):279-287. PubMed ID: 28577031
[TBL] [Abstract][Full Text] [Related]
13. Investigation of retinal nerve fiber layer thickness and ganglion cell layer-inner plexiform layer thickness in patients with optic pathway gliomas.
Hepokur M; Sarici AM
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1757-1765. PubMed ID: 29754292
[TBL] [Abstract][Full Text] [Related]
14. Visual function assessed by visually evoked potentials in optic pathway low-grade gliomas with and without neurofibromatosis type 1.
Dotto PF; Berezovsky A; Cappellano AM; da Silva NS; Sacai PY; Silva FAB; Fernandes AG; Rocha DM; Salomão SR
Doc Ophthalmol; 2018 Jun; 136(3):177-189. PubMed ID: 29766345
[TBL] [Abstract][Full Text] [Related]
15. Defining optic nerve tortuosity.
Armstrong GT; Localio AR; Feygin T; Bilaniuk L; Phillips PC; Fisher MJ; Strom BL; Zimmerman R
AJNR Am J Neuroradiol; 2007 Apr; 28(4):666-71. PubMed ID: 17416818
[TBL] [Abstract][Full Text] [Related]
16. Color-doppler Flow Imaging Might Help Diagnose Optic Nerve Glioma.
Chotard G; Farah E; Lecler A
Ophthalmology; 2021 Mar; 128(3):392. PubMed ID: 33612164
[No Abstract] [Full Text] [Related]
17. Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis.
Kornreich L; Blaser S; Schwarz M; Shuper A; Vishne TH; Cohen IJ; Faingold R; Michovitz S; Koplewitz B; Horev G
AJNR Am J Neuroradiol; 2001; 22(10):1963-9. PubMed ID: 11733333
[TBL] [Abstract][Full Text] [Related]
18. Application of diffusion tensor tractography in pediatric optic pathway glioma.
Lober RM; Guzman R; Cheshier SH; Fredrick DR; Edwards MS; Yeom KW
J Neurosurg Pediatr; 2012 Oct; 10(4):273-80. PubMed ID: 22900485
[TBL] [Abstract][Full Text] [Related]
19. Concomitant meningioma and glioma within the same optic nerve in neurofibromatosis type 1.
Büyükkapu-Bay S; Akça A; Karadoğan M; Çorapçioğlu F; Anik Y
J Child Neurol; 2014 Mar; 29(3):385-8. PubMed ID: 23420652
[TBL] [Abstract][Full Text] [Related]
20. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
Friedrich RE; Nuding MA
Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
